Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (±)bepridil and (−)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes
- 29 October 1985
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 132 (1), 49-55
- https://doi.org/10.1016/0006-291x(85)90986-6
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Properties of receptors for the Ca2+‐channel blocker verapamil in transverse‐tubule membranes of skeletal muscleEuropean Journal of Biochemistry, 1984
- Calcium antagonistic effects of the radioligand (−)-desmethoxy-verapamil on cardiac and vascular smooth muscle preparationsCell Calcium, 1984
- Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamilEuropean Journal of Biochemistry, 1984
- Cellular Action of Calcium Channel Blocking DrugsAnnual Review of Medicine, 1984
- [3H] verapamil binding sites in skeletal muscle tranverse tubule membranesBiochemical and Biophysical Research Communications, 1984
- 1,4‐Dihydropyridine Ca2+channel antagonists and activators: A comparison of binding characteristics with pharmacologyDrug Development Research, 1984
- Calcium antagonists: A new class of drugsPharmacology & Therapeutics, 1983
- [3H]verapamil binding sites in brain and skeletal muscle: Regulation by calciumEuropean Journal of Pharmacology, 1983
- Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazemThe American Journal of Cardiology, 1980
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977